Data / Form D filings / One Health Group, Inc.
One Health Group, Inc.: Form D filings
One Health Group, Inc., a biotechnology company in Cazenovia, NY, filed 6 Form D notices with the SEC between 2023 and 2024. The latest, on December 18, 2024, reports an offering of $5 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3053 WEST LAKE ROAD, Cazenovia, NY, 13035
- Phone
- (315) 815-4483
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 504, Rule 506(c)
- SEC identifier (CIK)
- 1972911
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| May 24, 2024 | New notice | $5,923,000 | $0 | $5,923,000 | 0 | Yet to occur | sec.gov |
| May 24, 2024 | Amendment | $2,577,000 | $2,577,000 | 8 | Aug 5, 2023 | sec.gov | |
| Feb 26, 2024 | Amendment | $3,000,000 | $2,429,000 | $571,000 | 8 | Aug 5, 2023 | sec.gov |
| Aug 29, 2023 | Amendment | $3,000,000 | $660,000 | $2,340,000 | 8 | Jul 17, 2023 | sec.gov |
| May 8, 2023 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carl Eckstein | Director | |
| Mark Wang | Director | |
| Albert Di Rienzo | Executive Officer, Director | |
| Michael Stanfield | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Dec 16, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what One Health Group, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.